CD5 and diffuse large B-cell lymphoma: CD5-positive (CD5+) DLBCL was defined as an immunohistochemical subtype in the fourth edition of the World Health Organization (WHO) classification, which takes up approximately 5% to 10% of DLBCL (13, 14).